First-in-Human Study of OKI-219 Alone and in Combination with Other Therapies in Patients with Solid Tumors / Breast Cancer
OKI-219-101
Phase 1 other active
Quick answer
First-in-Human Study of OKI-219 Alone and in Combination with Other Therapies in Patients with Solid Tumors / Breast Cancer for Advanced Solid Tumors, Advanced Breast Cancer is a Phase 1 program (other) at OnKure Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- OnKure Therapeutics
- Indication
- Advanced Solid Tumors, Advanced Breast Cancer
- Phase
- Phase 1
- Modality
- other
- Status
- active